Market Updates
Follow state and federal advertising rules, platform policy shifts, substantiation requirements, patient testimonial risks, and enforcement trends that affect clinic growth.
This page collects relevant market updates for clinic operators tracking changes in Advertising compliance. Use it to identify policy shifts, enforcement activity, operational risks, and strategic opportunities that may affect clinic growth, compliance, or service delivery.
Category Archive
Filter updates by state, jurisdiction, clinic type, service line, command zone, and impact level.
FDA reminded telehealth companies that compounded drug promotion can be false or misleading when it implies FDA approval, generic status, equivalent results, or unclear pharmacy sourcing.
Operator impact: Clinics should legal-review GLP-1 ads, landing pages, SMS, sales scripts, and patient education before scaling paid acquisition around compounded drugs.
FTC guidance requires health-related product claims to be truthful, not misleading, and supported by competent and reliable scientific evidence.
Operator impact: Clinics marketing peptides, supplements, IV therapy, regenerative products, devices, diagnostics, weight loss, hormones, or apps should audit express and implied claims across ads, landing pages, webinars, and sales scripts.
California Board of Pharmacy disciplinary records involving Tailormade Compounding alleged deceptive peptide guide and catalog content for substances including BPC-157, CJC-1295, PT-141, Thymosin Alpha-1, and Thymosin Beta-4.
Operator impact: Clinics and pharmacies should treat peptide education pages, protocol PDFs, provider sales decks, and website catalogs as advertising risk assets requiring evidence review and claim substantiation.
Relevant Clinic Market Briefings
A market briefing for medical weight loss clinics, med spas, telehealth clinics, and cash-pay operators navigating GLP-1 coverage changes, compounded GLP-1 pressure, Medicaid shifts, employer pullback, and the move toward metabolic care.
A market briefing for IV hydration clinics, mobile IV operators, med spas, and wellness clinics on prescriber orders, nursing scope, pharmacy rules, sterile compounding, emergency protocols, and state board scrutiny.
A market briefing for med spas, aesthetic clinics, and wellness clinics on supervision, delegation, injector scope, medical director duties, product sourcing, and state-level med spa regulation.
A Command.clinic market briefing on how GLP-1 compounding changes can affect cash-pay clinic offers, pharmacy sourcing, patient messaging, advertising claims, and retention economics.
Clinic Commanders
Get daily access to practical operator conversations, market updates, growth breakdowns, and peer support built for clinic owners who want clearer decisions without agency noise.
$9.99 first month. Then $99.99/month.
Built for clinic owners, operators, and practice leaders.
